Biomarkers are measurable biological characteristics—such as LDL cholesterol, blood pressure, or lipoprotein(a) [Lp(a)]—that serve as proxies for disease states. A surrogate endpoint, as defined by the FDA, is a substitute measure used in place of a direct clinical outcome (how a patient feels, functions, or survives).